Articles

Baseline cardiovascular risk assessment in cancer patients

This position statement from the Heart Failure Association of the European Society of Cardiology Cardio-Oncology Study Group in collaboration with the International Cardio-Oncology Society presents practical, easy-to-use and evidence-based risk stratification tools for oncologists, haemato-oncologists and cardiologists to use in their clinical practice to risk stratify oncology patients prior to receiving cancer therapies known to […]

Baseline cardiovascular risk assessment in cancer patients Read More »

5-FU based Chemotherapy and CV Toxicities | Radcliffe Cardiology

The International Cardio-Oncology Society is a committed group of professionals throughout the world who are striving to protect the cardiovascular health of all patients who are undergoing cancer therapy. By optimising the cardiac status of patients with cancer before, during and after their treatment, IC-OS are collectively improving the overall outcomes including survival and quality

5-FU based Chemotherapy and CV Toxicities | Radcliffe Cardiology Read More »

Machine learning based radiomics model to predict radiotherapy induced cardiotoxicity in breast cancer

Abstract Purpose: Cardiotoxicity is one of the major concerns in breast cancer treatment, significantly affecting patient outcomes. To improve the likelihood of favorable outcomes for breast cancer survivors, it is essential to carefully balance the potential advantages of treatment methods with the risks of harm to healthy tissues, including the heart. There is currently a lack

Machine learning based radiomics model to predict radiotherapy induced cardiotoxicity in breast cancer Read More »